Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Synergistic anti-leukemic activity with combination of FLT3 inhibitor quizartinib and MDM2 inhibitor milademetan in FLT3-ITD mutant/p53 wild-type acute myeloid leukemia models
I., & et al
Description Sermorelin + Ipamorelin Blend for Research Product Overview Sermorelin + Ipamorelin are two synthetic peptides known for their interaction with growth hormone regulatory pathways
Y250 is located much farther from the disulfide bonds (Cys128-Cys206 in the hinge region between K1 and K2 domains, and Cys211-Cys288, Cys232-Cys271, and Cys260-Cys283 in the K2 domain) than the distances between Y198 and disulfide bonds, Cys149-Cys189 and Cys177-Cys201
US$ 25.56
US$ 23.94
US$ 26.14
US$ 29.82
